AFL 📈 Aflac - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0010551028
AFL: Life Insurance, Health Insurance, Cancer Insurance, Disability Insurance
Aflac Incorporated is a leading provider of supplemental health and life insurance products, operating through two primary segments: Aflac Japan and Aflac U.S. The company's extensive range of products is designed to help individuals and families mitigate financial risks associated with unexpected medical expenses, disability, and death. In Japan, Aflac offers a diverse portfolio of insurance products, including cancer, medical, and nursing care insurance, as well as whole and term life insurance, and savings-type insurance products such as WAYS and child endowment plans.
The Aflac U.S. segment provides a broad array of insurance products, including cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care, and disability insurance, in addition to term and whole life insurance. These products are designed to help individuals and families in the United States manage financial risks and protect their assets. Aflac's distribution network is comprised of sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies, allowing the company to effectively reach a wide range of customers.
With a history dating back to 1955, Aflac Incorporated has established itself as a trusted and reliable provider of supplemental insurance products. The company is headquartered in Columbus, Georgia, and its common stock is listed on the New York Stock Exchange (NYSE) under the ticker symbol AFL. Aflac's website, https://www.aflac.com, provides detailed information on its products, services, and investor relations. The company's ISIN is US0010551028, and it is classified under the GICS Sub Industry of Life & Health Insurance, reflecting its focus on providing essential insurance products to individuals and families.
Additional Sources for AFL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AFL Stock Overview
Market Cap in USD | 58,064m |
Sector | Financial Services |
Industry | Insurance - Life |
GiC Sub-Industry | Life & Health Insurance |
IPO / Inception | 1984-07-19 |
AFL Stock Ratings
Growth 5y | 88.4% |
Fundamental | 12.2% |
Dividend | 69.4% |
Rel. Strength Industry | -9.11 |
Analysts | 3.08/5 |
Fair Price Momentum | 109.27 USD |
Fair Price DCF | 149.35 USD |
AFL Dividends
Dividend Yield 12m | 2.51% |
Yield on Cost 5y | 5.55% |
Annual Growth 5y | 9.24% |
Payout Consistency | 95.5% |
AFL Growth Ratios
Growth Correlation 3m | -51.1% |
Growth Correlation 12m | 92% |
Growth Correlation 5y | 97.2% |
CAGR 5y | 17.12% |
CAGR/Mean DD 5y | 1.97 |
Sharpe Ratio 12m | 1.12 |
Alpha | 0.74 |
Beta | 1.10 |
Volatility | 28.32% |
Current Volume | 4847.5k |
Average Volume 20d | 2273.3k |
As of December 21, 2024, the stock is trading at USD 102.69 with a total of 4,847,500 shares traded.
Over the past week, the price has changed by -1.75%, over one month by -6.85%, over three months by -4.42% and over the past year by +29.96%.
Neither. Based on ValueRay Fundamental Analyses, Aflac is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.19 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFL as of December 2024 is 109.27. This means that AFL is currently overvalued and has a potential downside of 6.41%.
Aflac has received a consensus analysts rating of 3.08. Therefor, it is recommend to hold AFL.
- Strong Buy: 1
- Buy: 2
- Hold: 8
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, AFL Aflac will be worth about 120.2 in December 2025. The stock is currently trading at 102.69. This means that the stock has a potential upside of +17.03%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 105.8 | 3% |
Analysts Target Price | 77.1 | -24.9% |
ValueRay Target Price | 120.2 | 17% |